Prokopiw I, Dinda P K, Beck I T
Department of Medicine, Queen's University, Hotel Dieu Hospital, Kingston, Ont., Canada.
Can J Physiol Pharmacol. 1990 Dec;68(12):1563-7. doi: 10.1139/y90-238.
In the present study we have compared the effect of intravenous infusion of a calcium channel blocker, nifedipine (1.0 micrograms.kg-1.min-1 for 20 min), with that of isoproterenol (0.1 micrograms.kg-1.min-1 for 20 min) on the hemodynamic parameters and the vascular response of different locations and tissue layers of the gastrointestinal tract. Heart rate increased with isoproterenol but not with nifedipine. Both agents caused a similar increase in cardiac output and a similar fall in mean arterial pressure. After 20 min infusion, nifedipine increased the blood flow of the axillary artery, but isoproterenol had no such effect. Isoproterenol caused vasodilation of the mucosa in the antrum but not in the fundus and the body of the stomach or in the duodenum, jejunum, mid small intestine, ileum, and colon. The mucosal effect of nifedipine was similar, except that it also caused vasodilation in the small bowel and in the ascending colon. Nifedipine caused vasodilation of the muscularis throughout the gastrointestinal tract, but isoproterenol had no such effect. These differences are discussed in relation to the mechanism of action of these two vasodilators. It is suggested that the vascular response of different locations and tissue layers of the gastrointestinal tract to vasodilators is locally regulated by a variety of mechanisms may include beta- and alpha-receptor density and (or) sensitivity, angiotensin II activity, and metabolic need of the tissues.
在本研究中,我们比较了静脉输注钙通道阻滞剂硝苯地平(1.0微克·千克⁻¹·分钟⁻¹,持续20分钟)和异丙肾上腺素(0.1微克·千克⁻¹·分钟⁻¹,持续20分钟)对血流动力学参数以及胃肠道不同部位和组织层血管反应的影响。异丙肾上腺素使心率增加,而硝苯地平则无此作用。两种药物均使心输出量有相似的增加,平均动脉压有相似的下降。输注20分钟后,硝苯地平使腋动脉血流增加,而异丙肾上腺素无此作用。异丙肾上腺素使胃窦黏膜血管舒张,但对胃底、胃体、十二指肠、空肠、中小肠、回肠和结肠无此作用。硝苯地平的黏膜作用相似,只是它还使小肠和升结肠血管舒张。硝苯地平使整个胃肠道肌层血管舒张,而异丙肾上腺素无此作用。针对这两种血管舒张剂的作用机制对这些差异进行了讨论。有人提出,胃肠道不同部位和组织层对血管舒张剂的血管反应受多种机制的局部调节,这些机制可能包括β和α受体密度及(或)敏感性、血管紧张素II活性以及组织的代谢需求。